7Saito S,Takayama T,Honye J. Effect of lipid-lowering therapy on plaque volume and composition in patient with coronary artery disease evaluated by three dimensional intravascular ultrasound[J].The American Journal of Chinese Medicine,2002,(11):143-146.
9Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3- methyl-glutaryl Coa reductase inhibitors prevent high glucose -indluced proliferation of nesangial cells via modulation of Rho GTPase/p2/sigmaling pathway [J]. Implications for diabetic nedphropathy Proc Nat Acad Scius, 2002,99 : 8 301 - 8 305.
10National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification [J] . Am JKidney Dis, 2002, 39 (2 Suppl 1) : S1-266.
4Kanwar YS,Sun L,Xie P,et al.A glimpse of various pathogenetic mechanisms of diabetic nephropathy[J].Annu Rev Pathol,2011,28(6):395.
5Rosario RF,Prabhakar S.Lipids and diabetic nephropathy[J].Curr Diab Rep,2006,6(6):455.
6Agarwal R.Effects of statins on renal function[J].Am J Cardiol,2006,97(5):748.
7Devaraj S,Dasu MR,Jialal I.Diabetes is a proinflammatory state: a translational perspective[J].Expert Rev Endocrinol Metab,2010,5(l):19-28. PMID: 20204165.
8Gensini GF,Gori AM,Dilaghi B,et al.Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study[J].Int J Cardiol,2010,142(3):257-6d. DOI: 10. 1016/j.ijcard.2008.12.213.
9Igoillo-Esteve M,Marselli L,Cunha DA,et al.Palmitate induces a pro-inflammatory response in human pancreatic islets thai mimics CCL2 expression by beta cells in type 2 diabetes[J].Diahetolog ia,2010,53(7): 1395-1405. DOI: 10.1007/s00125-010-1707-y.
10Boni-Schnetzler M,Thorne J,Parnaud G,et al.Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation[J].J Clin Endocrinol Metab,2008,93(10):4065-4074. DOI: 1 0.1210/jc.2008-0396.
